Pathogenesis: Insulin-dependent, non-insulin dependent, and transient
Pathogenesis
Diagnosis
Patient evaluation
Insulin choices
type
Source
Conc
Route
Onset
Duration(d)
Duration©
regular
Human recom
100U/ml
IV
immed
1-2 h
1-2 h
IM
10-30 min
2-6
2-6
SC
30-60 min
2-6
2-6
NPH
Human recom
100 U/ml
SC
0.5-2 h
4-12
4-6
Lente (VetsulinTM)
Pork
40 U/ml
SC
0.5-2 h
6-16
4-16*
PZI
Beef/Pork
40 U/ml
SC
0.5-4 h
6-16
6-16**
PZI (Pro ZincTM)
Human
Recom
40 U/ml
SC
0.5-4 h
6-16
6-16
Glargine
LantusTM
Human mutated
100 U/ml
SC
0.5-1 h
6-16
6-16
Detemir
LevemirTM
Human
mutated
100 U/ml
SC
0.5-1 hr
6-16
6-16
Lispro -HumalogTM
Aspart -NovoLogTM
Human mutated
100 U/L
SC
15 min
2-6 hrs.
2-6 hrs
Short/intermediate acting mixtures
50/50
70/30
75/25
Mixtures of insulins
** No longer available by IDEXX. Some compounding pharmacies are selling their own compounds